Lide Biotech
LIDE is an award winning preclinical oncology CRO offering traditional services like 2D and 3D in-vitro assays, 1900 in-vivo PDX models covering 50 indications, CDX models, conditionally reprogrammed cell lines, and immuno-oncology studies with syngeneic or humanized mice. We also have novel in-vivo options to validate ADCs with fresh patient samples, as well as faster studies using our proprietary MiniPDX and IO-FIVE assays
